The U.S. ITC has denied a request by Masimo to reinstate a ban on the Apple Watch, closing its case on alleged blood oxygen patent infringement.
The rear sensor of the Apple Watch
The rear sensor of the Apple Watch
The long-running lawsuit over the Apple Watch has continued, this time with a partial win for Apple. In the latest development, which saw Masimo accuse Apple of infringing on its blood oxygen patents, the medical tech firm was denied a review of a preliminary ruling.
On March 19, the U.S. Court of Appeal for the Federal Circuit backed the original ruling by the International Trade Commission. However, on March 18, the ITC made a ruling that Apple wouldn’t have to do anything else to remedy the case.